| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,980 |
17,434 |
$5.05M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
35,359 |
31,295 |
$4.79M |
| A0999 |
Unlisted ambulance service |
5,114 |
4,145 |
$3.68M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,431 |
2,291 |
$2.06M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,695 |
2,346 |
$1.76M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,261 |
5,735 |
$964K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,488 |
3,223 |
$717K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,811 |
2,641 |
$708K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,215 |
7,815 |
$650K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,125 |
1,984 |
$526K |
| A0425 |
Ground mileage, per statute mile |
12,621 |
8,508 |
$481K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,916 |
5,226 |
$443K |
| 80053 |
Comprehensive metabolic panel |
23,155 |
19,879 |
$417K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,609 |
4,285 |
$412K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,602 |
2,806 |
$398K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,303 |
1,250 |
$389K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
7,489 |
5,511 |
$380K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,385 |
2,511 |
$369K |
| 36415 |
Collection of venous blood by venipuncture |
34,777 |
28,976 |
$338K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
3,887 |
3,039 |
$337K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,908 |
20,998 |
$317K |
| 71046 |
Radiologic examination, chest; 2 views |
3,643 |
3,416 |
$281K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,346 |
3,211 |
$279K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
325 |
313 |
$278K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,080 |
1,067 |
$266K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,757 |
5,031 |
$237K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,190 |
7,753 |
$208K |
| 71045 |
Radiologic examination, chest; single view |
3,392 |
3,101 |
$200K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,389 |
2,830 |
$193K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,810 |
3,855 |
$188K |
| 96376 |
|
2,075 |
1,513 |
$173K |
| 83690 |
|
13,086 |
11,225 |
$171K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,107 |
1,067 |
$160K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,986 |
2,847 |
$153K |
| 80061 |
Lipid panel |
6,028 |
5,911 |
$143K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,565 |
1,493 |
$135K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,655 |
1,400 |
$118K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
864 |
852 |
$117K |
| 80050 |
General health panel |
1,169 |
1,119 |
$116K |
| 76830 |
Ultrasound, transvaginal |
782 |
757 |
$115K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
331 |
312 |
$111K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,012 |
1,702 |
$94K |
| 87481 |
|
901 |
821 |
$93K |
| 97161 |
|
998 |
970 |
$86K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
502 |
290 |
$84K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
864 |
821 |
$84K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,151 |
5,024 |
$83K |
| 87631 |
|
681 |
619 |
$81K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,584 |
2,464 |
$75K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,584 |
2,465 |
$74K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,690 |
1,866 |
$73K |
| 73630 |
|
908 |
861 |
$66K |
| 73610 |
|
858 |
814 |
$66K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
496 |
478 |
$66K |
| 84484 |
|
3,191 |
2,656 |
$65K |
| 81001 |
|
7,112 |
6,441 |
$65K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,988 |
3,447 |
$58K |
| 81025 |
|
4,574 |
4,166 |
$57K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,712 |
3,434 |
$54K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,014 |
1,842 |
$53K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
598 |
506 |
$51K |
| 87070 |
|
2,904 |
2,716 |
$45K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,127 |
1,374 |
$45K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
366 |
332 |
$43K |
| 80306 |
|
2,130 |
1,963 |
$38K |
| 73030 |
|
491 |
466 |
$37K |
| 81003 |
|
5,179 |
4,713 |
$36K |
| 85610 |
|
2,757 |
1,853 |
$32K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
826 |
802 |
$31K |
| 82728 |
|
1,326 |
1,277 |
$30K |
| 72100 |
|
253 |
248 |
$30K |
| 83735 |
|
2,932 |
2,443 |
$29K |
| 84439 |
|
1,635 |
1,576 |
$29K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,041 |
2,754 |
$29K |
| 73110 |
|
364 |
340 |
$27K |
| 86803 |
|
1,126 |
1,083 |
$27K |
| 76801 |
|
176 |
159 |
$26K |
| 84466 |
|
1,357 |
1,304 |
$26K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
222 |
170 |
$25K |
| 83880 |
|
637 |
572 |
$24K |
| G0378 |
Hospital observation service, per hour |
93 |
48 |
$24K |
| 73130 |
|
287 |
278 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,255 |
1,199 |
$23K |
| 86850 |
|
829 |
780 |
$22K |
| 87430 |
|
1,067 |
1,037 |
$22K |
| 82570 |
|
1,212 |
1,142 |
$21K |
| 86900 |
|
922 |
851 |
$21K |
| 87181 |
|
2,234 |
2,085 |
$20K |
| 82607 |
|
847 |
813 |
$19K |
| 85651 |
|
1,323 |
1,236 |
$19K |
| 87077 |
|
1,281 |
1,192 |
$17K |
| 85027 |
|
1,864 |
1,568 |
$17K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,426 |
1,124 |
$16K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
537 |
526 |
$15K |
| 83605 |
|
940 |
789 |
$15K |
| 83540 |
|
1,389 |
1,335 |
$14K |
| 84153 |
|
391 |
378 |
$13K |
| 86140 |
|
1,272 |
1,160 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
566 |
549 |
$13K |
| 86901 |
|
923 |
852 |
$13K |
| 84702 |
|
383 |
291 |
$11K |
| 87276 |
|
681 |
652 |
$10K |
| 97535 |
Self-care/home management training, each 15 minutes |
334 |
256 |
$10K |
| 73564 |
|
73 |
68 |
$10K |
| 81514 |
|
173 |
164 |
$9K |
| 87275 |
|
681 |
652 |
$9K |
| 76642 |
|
116 |
103 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
246 |
205 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
1,520 |
1,014 |
$8K |
| 80143 |
|
173 |
164 |
$8K |
| 90715 |
|
126 |
124 |
$7K |
| 82043 |
|
758 |
742 |
$7K |
| 73562 |
|
104 |
99 |
$7K |
| 97162 |
|
74 |
74 |
$7K |
| 87205 |
|
912 |
808 |
$7K |
| 12001 |
|
76 |
65 |
$6K |
| 86592 |
|
708 |
684 |
$6K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
38 |
37 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
201 |
190 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
272 |
189 |
$6K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
15 |
14 |
$5K |
| 73140 |
|
53 |
50 |
$5K |
| 87340 |
|
240 |
229 |
$5K |
| 93971 |
|
36 |
36 |
$5K |
| 87040 |
|
251 |
132 |
$5K |
| 82550 |
|
426 |
375 |
$5K |
| 82746 |
|
198 |
188 |
$5K |
| 84481 |
|
163 |
161 |
$4K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
14 |
12 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
120 |
117 |
$4K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
119 |
85 |
$4K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
12 |
12 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
554 |
387 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
139 |
132 |
$3K |
| 93975 |
|
13 |
12 |
$3K |
| J3490 |
Unclassified drugs |
123 |
82 |
$3K |
| 96367 |
|
73 |
56 |
$3K |
| 85730 |
|
165 |
145 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
93 |
64 |
$2K |
| 84100 |
|
232 |
199 |
$2K |
| 97116 |
|
62 |
29 |
$2K |
| 85379 |
|
51 |
51 |
$2K |
| 10060 |
|
14 |
14 |
$2K |
| 84550 |
|
132 |
124 |
$2K |
| 72070 |
|
16 |
16 |
$2K |
| 82803 |
|
58 |
51 |
$1K |
| 86696 |
|
38 |
38 |
$1K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
52 |
49 |
$957.56 |
| 86695 |
|
38 |
38 |
$858.76 |
| 83615 |
|
66 |
53 |
$802.74 |
| 87797 |
|
24 |
24 |
$798.90 |
| 84703 |
|
41 |
40 |
$741.04 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
31 |
26 |
$733.96 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
119 |
93 |
$680.24 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
14 |
14 |
$636.23 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
71 |
66 |
$612.01 |
| 82950 |
|
50 |
50 |
$602.90 |
| 82150 |
|
40 |
37 |
$584.83 |
| 86038 |
|
28 |
28 |
$584.15 |
| 86787 |
|
29 |
27 |
$581.62 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
59 |
43 |
$522.20 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
52 |
38 |
$476.48 |
| 94664 |
|
12 |
12 |
$401.49 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
58 |
33 |
$345.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
31 |
$312.49 |
| 82009 |
|
15 |
12 |
$310.66 |
| 87046 |
|
24 |
12 |
$290.68 |
| 80320 |
|
85 |
75 |
$283.68 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
70 |
61 |
$252.44 |
| 86762 |
|
12 |
12 |
$241.11 |
| 36416 |
|
31 |
27 |
$205.44 |
| 87045 |
|
12 |
12 |
$145.34 |
| 83721 |
|
12 |
12 |
$115.10 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
19 |
17 |
$100.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
73 |
68 |
$93.06 |
| 84436 |
|
12 |
12 |
$91.81 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
21 |
19 |
$47.99 |
| 80329 |
|
42 |
39 |
$47.04 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
20 |
15 |
$34.16 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
19 |
19 |
$28.24 |
| A9270 |
Non-covered item or service |
22,065 |
8,454 |
$17.52 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
12 |
$0.00 |